- Home
- LPCN vs SMTK Comparison
LPCN vs SMTK Comparison
Compare LPCN & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SMTK
- Stock Information
- Founded
- LPCN 1997
- SMTK 2009
- Country
- LPCN United States
- SMTK United Kingdom
- Employees
- LPCN N/A
- SMTK N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SMTK
- Sector
- LPCN Health Care
- SMTK
- Exchange
- LPCN Nasdaq
- SMTK NYSE
- Market Cap
- LPCN 16.1M
- SMTK 13.3M
- IPO Year
- LPCN N/A
- SMTK N/A
- Fundamental
- Price
- LPCN $3.10
- SMTK $2.23
- Analyst Decision
- LPCN Strong Buy
- SMTK
- Analyst Count
- LPCN 1
- SMTK 0
- Target Price
- LPCN $10.00
- SMTK N/A
- AVG Volume (30 Days)
- LPCN 10.3K
- SMTK 76.9K
- Earning Date
- LPCN 05-08-2025
- SMTK 05-12-2025
- Dividend Yield
- LPCN N/A
- SMTK N/A
- EPS Growth
- LPCN N/A
- SMTK N/A
- EPS
- LPCN N/A
- SMTK N/A
- Revenue
- LPCN $11,198,144.00
- SMTK $82,000.00
- Revenue This Year
- LPCN N/A
- SMTK N/A
- Revenue Next Year
- LPCN N/A
- SMTK N/A
- P/E Ratio
- LPCN N/A
- SMTK N/A
- Revenue Growth
- LPCN N/A
- SMTK 203.70
- 52 Week Low
- LPCN $2.75
- SMTK $2.01
- 52 Week High
- LPCN $11.79
- SMTK $13.00
- Technical
- Relative Strength Index (RSI)
- LPCN 46.56
- SMTK N/A
- Support Level
- LPCN $2.82
- SMTK N/A
- Resistance Level
- LPCN $3.27
- SMTK N/A
- Average True Range (ATR)
- LPCN 0.23
- SMTK 0.00
- MACD
- LPCN 0.01
- SMTK 0.00
- Stochastic Oscillator
- LPCN 58.92
- SMTK 0.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.